440 related articles for article (PubMed ID: 26692097)
21. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
22. Predictive Factors of Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Zhao W; Chen S; Hou X; Liao Q; Chen G; Zhao Y
Pathol Oncol Res; 2019 Jul; 25(3):1245-1251. PubMed ID: 30361912
[TBL] [Abstract][Full Text] [Related]
23. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
24. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer.
Ahn D; Heo SJ; Park JH; Kim JH; Sohn JH; Park JY; Park SK; Park J
Acta Oncol; 2011 Nov; 50(8):1228-34. PubMed ID: 21871002
[TBL] [Abstract][Full Text] [Related]
25. Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma.
Uhliarova B; Hajtman A
Braz J Otorhinolaryngol; 2018; 84(6):729-735. PubMed ID: 28964693
[TBL] [Abstract][Full Text] [Related]
26. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathologic analysis of 254 cases of papillary thyroid microcarcinoma].
Fu X; Lou S; Shi H; Liu Q; Chen Z; Zhou Y
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):258-61. PubMed ID: 25975909
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
30. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
31. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.
Chen S; Niu C; Peng Q; Tang K
Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.
Yang Z; Wang X; Tao T; Zou J; Qiu Z; Wang L; Du H; Chen N; Yin X
BMC Surg; 2023 Oct; 23(1):325. PubMed ID: 37875825
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
[No Abstract] [Full Text] [Related]
35. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
37. Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma.
Kim YS
Otolaryngol Head Neck Surg; 2012 Jul; 147(1):15-9. PubMed ID: 22399280
[TBL] [Abstract][Full Text] [Related]
38. Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study.
Lai X; Zhang B; Jiang Y; Li J; Zhao R; Yang X; Zhang X; Zhu S; Wu Q; Cai S; Zhang Y
PLoS One; 2016; 11(2):e0148567. PubMed ID: 26881783
[TBL] [Abstract][Full Text] [Related]
39. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
40. Predicting the factors of lateral lymph node metastasis in papillary microcarcinoma of the thyroid in eastern China.
Zeng RC; Li Q; Lin KL; Zhang W; Gao EL; Huang GL; Zhang XH; Zheng MH
Clin Transl Oncol; 2012 Nov; 14(11):842-7. PubMed ID: 22872517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
